Beijing Airdoc Technology Co Ltd is a China-based company primarily focusing on providing AI-empowered retina-based early detection, diagnosis and health risk assessment solutions. Along with its subsidiaries, The Company’s portfolio products include Retinal AI products, which encompasses SaMDs for detection and diagnosis, health risk assessment solutions, and AI-empowered hardware devices, forming an integrated solution of AI-based software and hardware. The Company has launched AI-empowered treatment products targeting myopia, strabismus, and amblyopia in children and adolescents, achieving a one-stop solution that ranging from detection to assessment to treatment. The Company's market coverage serves the clinical departments of hospitals, healthcare institutions, consumer health environments, and eye health management settings. The Company mainly conducts its businesses in the domestic market and overseas markets.